Oxipit
Oxipit is a leading AI-driven medical imaging company founded in 2017 by experts in medicine and data science. The company develops autonomous and advanced AI solutions for radiology, including the CE Class IIb-certified ChestLink, the world's first autonomous AI imaging application for chest X-rays, and ChestEye, which supports preliminary reporting for 75 chest X-ray findings. Oxipit's AI solutions automate up to 40% of radiology workflows, addressing the global shortage of radiologists and improving diagnostic accuracy and patient outcomes. Trusted worldwide by healthcare providers and integrated with major healthcare IT systems, Oxipit continues to expand its portfolio into CT and musculoskeletal imaging, positioning itself as a pioneer in AI-powered diagnostics and radiology workflow transformation.
Oxipit
Oxipit is a leading AI-driven medical imaging company founded in 2017 by experts in medicine and data science. The company develops autonomous and advanced AI solutions for radiology, including the CE Class IIb-certified ChestLink, the world's first autonomous AI imaging application for chest X-rays, and ChestEye, which supports preliminary reporting for 75 chest X-ray findings. Oxipit's AI solutions automate up to 40% of radiology workflows, addressing the global shortage of radiologists and improving diagnostic accuracy and patient outcomes. Trusted worldwide by healthcare providers and integrated with major healthcare IT systems, Oxipit continues to expand its portfolio into CT and musculoskeletal imaging, positioning itself as a pioneer in AI-powered diagnostics and radiology workflow transformation.
TL;DR
Founded: 2017 in Vilnius, Lithuania
Product focus: CE-certified AI for chest X‑ray (ChestEye) and autonomous ChestLink (CE Class IIb)
Funding (reported): Seed $1.7M (2019); $4.9M round (Jan 2023)
Employee count (reported): 20
Company Overview
Problem Domain
Radiology workflow automation and chest X‑ray interpretation
Founded
2017
Industry
Health care; Medical imaging AI
Funding Track Record
1700000.00
Seed round announced June 15, 2019 with angel participation.
4900000.00
Funding round closed January 19, 2023; company reporting $4.9M.
Investor Signal
“Practica Capital is a recurring lead investor”